Avoid Excessive Use of Advair HFA and Avoid Use with Other Long-acting Beta2-agonists Do not exceed the recommended dose. Fatalities have been reported with excessive use of inhaled ...

Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... patients to double the dose of their inhaled ...

The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...